Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.

ABSTRACT:

Objective

Treatment-resistant depression (TRD) occurs in roughly one-third of all individuals with major depressive disorder (MDD). Although research has suggested a significant common variant genetic component of liability to TRD, with heritability estimated at 8% when compared with non-treatment-resistant MDD, no replicated genetic loci have been identified, and the genetic architecture of TRD remains unclear. A key barrier to this work has been the paucity of adequately powered cohorts for investigation, largely because of the challenge in prospectively investigating this phenotype. The objective of this study was to perform a well-powered genetic study of TRD.

Methods

Using receipt of electroconvulsive therapy (ECT) as a surrogate for TRD, the authors applied standard ma

SUBMITTER: Kang J 

PROVIDER: S-EPMC11905962 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature